000 01467 a2200433 4500
005 20250517093137.0
264 0 _c20170406
008 201704s 0 0 eng d
022 _a1885-5857
024 7 _a10.1016/j.rec.2016.02.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCosin-Sales, Juan
245 0 0 _aReal-world Data on the Efficacy of Vernakalant for Pharmacological Cardioversion in Patients With Recent-onset Atrial Fibrillation.
_h[electronic resource]
260 _bRevista espanola de cardiologia (English ed.)
_cJun 2016
300 _a619-20 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAcute Disease
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnisoles
_xtherapeutic use
650 0 4 _aAnti-Arrhythmia Agents
_xtherapeutic use
650 0 4 _aAtrial Fibrillation
_xdrug therapy
650 0 4 _aEmergency Service, Hospital
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPyrrolidines
_xtherapeutic use
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aLoscos, Armando
700 1 _aPeiró, Ana
700 1 _aSorando, M Rosa
700 1 _aBuendía, Francisco
700 1 _aRuescas, Luis
773 0 _tRevista espanola de cardiologia (English ed.)
_gvol. 69
_gno. 6
_gp. 619-20
856 4 0 _uhttps://doi.org/10.1016/j.rec.2016.02.020
_zAvailable from publisher's website
999 _c25975121
_d25975121